NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

NCT02390297

Active Not RecruitingN/A

Sponsor: Calimmune, Inc.

Conditions: HIV-1 Infection, Receipt of Cal-1 Modified Hematopoietic Cellular Products

Interventions: Blood tests

Countries: United States

Long term safety follow-up of Cal-1 recipients

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Signed informed consent
* Previous treatment with the Cal-1 modified hematopoietic cellular products

Exclusion Criteria:

* Inability to understand and provide informed consent

Locations (2)

Los Angeles, California, United States
San Francisco, California, United States